Open access · CC-BY
via OpenAlex
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
Fedor Levin, Daniel Ferreira, Catharina Lange, Martin Dyrba, Eric Westman, Ralph Buchert, Stefan Johannes Teipel, Michel J. Grothe, Alzheimer’s Disease Neuroimaging Initiative
Alzheimer s Research & Therapy · 2021 · ▲ 108 citations
Abstract
BACKGROUND: Previous research has described distinct subtypes of Alzheimer's disease (AD) based on the differences in regional patterns of brain atrophy on MRI. We conducted a data-driven exploration of distinct AD neurodegeneration subtypes using FDG-PET as a sensitive molecular imaging marker of neurodegenerative processes. METHODS: Hierarchical clustering of voxel-wise FDG-PET data from 177 amyloid-positive patients with AD dementia enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI) was used to identify distinct hypometabolic subtypes of AD, which were then further characterized with respect to clinical and biomarker characteristics. We then classified FDG-PET scans of 217 amyloid-positive patients with mild cognitive impairment ("prodromal AD") according to the identified subtypes and studied their domain-specific cognitive trajectories and progression to dementia over a follow-up interval of up to 72 months. RESULTS: Three main hypometabolic subtypes were identified: (i) "typical" (48.6%), showing a classic posterior temporo-parietal hypometabolic pattern; (ii) "limbic-predominant" (44.6%), characterized by old age and a memory-predominant cognitive profile; and (iii) a relatively rare "cortical-predominant" subtype (6.8%) characterized by younger age and more severe executive dysfunction. Subtypes classified in the prodromal AD sample demonstrated similar subtype characteristics as in the AD dementia sample and further showed differential courses of cognitive decline. CONCLUSIONS: These findings complement recent research efforts on MRI-based identification of distinct AD atrophy subtypes and may provide a potentially more sensitive molecular imaging tool for early detection and characterization of AD-related neurodegeneration variants at prodromal disease stages.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13195-021-00785-9
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Levin, F., Ferreira, D., Lange, C., Dyrba, M., Westman, E., Buchert, R., Teipel, S.J., Grothe, M.J., & Initiative, A.D.N. (2021). Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration. <em>Alzheimer s Research & Therapy</em>. https://doi.org/10.1186/s13195-021-00785-9
Vancouver
Levin F, Ferreira D, Lange C, Dyrba M, Westman E, Buchert R, et al. Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration. Alzheimer s Research & Therapy. 2021. doi:10.1186/s13195-021-00785-9.
BibTeX
@article{fedor2021Datadr,
title = {Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration},
author = {Fedor Levin and Daniel Ferreira and Catharina Lange and Martin Dyrba and Eric Westman and Ralph Buchert and Stefan Johannes Teipel and Michel J. Grothe and Alzheimer’s Disease Neuroimaging Initiative},
journal = {Alzheimer s Research & Therapy},
year = {2021},
doi = {10.1186/s13195-021-00785-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Dementia & Neuropsychologia 2016
Open access · CC-BY
Subjective cognitive decline: The first clinical manifestation of Alzheimer's disease?
2014
Citation only
Effects of genetic variation on the dynamics of neurodegeneration in Alzheimer's disease
Mayo Clinic 2011
Open access · US-GOV
DaTSCAN Imaging in Aging and Neurodegenerative Disease
Brain 2023
Open access · CC-BY
The potential of blood neurofilament light as a marker of neurodegeneration for Alzheimer's disease
Current Opinion in Neurology 2013
Citation only
Impact of brain aging and neurodegeneration on cognition
NeuroImage 2026
Citation only